Alkermes Plc
F:8AK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Alkermes Plc
F:8AK
|
IE |
|
A
|
Advanced Biomedical Technologies Inc
OTC:ABMT
|
US |
|
E
|
Eugene Special Purpose Acquisition 6 Co
KOSDAQ:373340
|
KR |
|
Mikron Holding AG
F:MH4N
|
CH |
|
S
|
Stamper Oil & Gas Corp
SWB:TMP
|
CA |
Wall St Price Targets
8AK Price Targets Summary
Alkermes Plc
According to Wall Street analysts, the average 1-year price target for 8AK is 29.37 EUR with a low forecast of 20.06 EUR and a high forecast of 39.51 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 8AK's stock price target?
Price Target
29.37
EUR
According to Wall Street analysts, the average 1-year price target for 8AK is 29.37 EUR with a low forecast of 20.06 EUR and a high forecast of 39.51 EUR.
What is the Revenue forecast for Alkermes Plc?
Projected CAGR
13%
Over the last 11 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 13%.
What is the Gross Profit forecast for Alkermes Plc?
Projected CAGR
13%
Over the last 11 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 8 years is 13%.
What is the Operating Income forecast for Alkermes Plc?
Projected CAGR
25%
The compound annual growth rate for Operating Income over the next 8 years is 25%.
What is the Pre-Tax Income forecast for Alkermes Plc?
Projected CAGR
7%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 7%.
What is the Net Income forecast for Alkermes Plc?
Projected CAGR
24%
The compound annual growth rate for Net Income over the next 8 years is 24%.
